Nova Eye Medical

2RT^®: Rewrites the Treatment of Macular Degeneration

Nova Eye Medical and its subsidiary AlphaRet (which commercializes 2RT^® technology) are committed to developing new treatment technologies that promote clinical outcomes and improve patients' quality of life.

2RT^® is a non-invasive, nanopulse laser therapy designed to slow the progression of AMD. 2RT^® works by stimulating the rejuvenation of cells in the retina to initiate a healing response that targets the underlying causes of AMD.

Website:

www.alpha-ret.com